Transforming Pathogen Detection
ExcaliVir is a molecular diagnostics company that is transforming pathogen detection by combining next generation microarray and sequencing. The company’s primary focus is the diagnosis and management of cancer.
ExcaliVir’s proprietary technology, PathoChip, is the most extensive microarray platform available for pathogen detection, providing fast, accurate detection of pathogens that may cause or complicate a disease, impacting treatment, prognosis, and follow-up. Using the Pathochip as a discovery engine, we are identifying specific microbial signatures associated with cancer, providing biomarkers to enhance diagnostic screening, assessment of the aggressiveness of the cancer, selection of targeted therapies, and monitoring for recurrence.